Luciano De Carlis

Luciano De Carlis

Auto-generated profile, based on publicly available information

Luciano De Carlis

Department of General Surgery and Transplantation, Niguarda Ca' Granda Hospital, Milan, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in The American Journal of Surgery
Verified
Journal Article
Closed access
AGAlessandro Giacomoni
Alessandro Giacomoni
GCGiacomo Concone
Giacomo Concone
SSStefano Di Sandro
Stefano Di Sandro
Andrea LauterioAndrea Lauterio
Andrea Lauterio
LCLuciano De Carlis
Luciano De Carlis

1 September 2014
Verified
Journal Article
Closed access
LCLuciano De Carlis
Luciano De Carlis
RSRaffaella Sguinzi
Raffaella Sguinzi
RCRiccardo De Carlis
Riccardo De Carlis
SSStefano Di Sandro
Stefano Di Sandro
JMJacopo Mangoni
Jacopo Mangoni
AVAngelo Vanzulli
Angelo Vanzulli

3 November 2010
Verified
Journal Article
Closed access
BDBogdan Dorobanţu
Bogdan Dorobanţu
VBVlad Brasoveanu
Vlad Brasoveanu
EMEmil Matei
Emil Matei
DODima Simona Olimpia
Dima Simona Olimpia
AGAlessandro Giacomoni
Alessandro Giacomoni
LCLuciano De Carlis
Luciano De Carlis

23 February 2012 in Hepatogastroenterology
Verified
Journal Article
Closed access
SSStefano Di Sandro
Stefano Di Sandro
AGAlessandro Giacomoni
Alessandro Giacomoni
ASAbdallah Slim
Abdallah Slim
Andrea LauterioAndrea Lauterio
Andrea Lauterio
IMIacopo Mangoni
Iacopo Mangoni
LCLuciano De Carlis
Luciano De Carlis
LDLT may represent a valid therapeutic option allowing several advantages for patients affected by HCC and waiting for liver transplantation (LT). However, some reports show a worse long term survival and disease free survival among patients treated by LDLT for HCC than deceased donor liver transplantation (DDLT) recipients. Among 1145 LT patients, 63 received LDLT. From January 2000 to December 2008, 179 patients underwent LT due to HCC, 30 (16.7%) received LDLT and 154 (86.0%) received DDLT. Patients were selected based on the Milan criteria. TACE, radiofrequency ablation, percutaneous alcoholization, or liver resection were applied as downstaging procedures, while on the waiting list. Overall 3- and 5-year survival rate was 77.3% and 68.7% vs. 82.8% and 76.7%, respectively for LDLT and DDLT recipient with not significant differences. Moreover, 3- and 5- years of recurrence free survival rate was 95.5% (LDLT) vs. 90.5% and 89.4% (DDLT) and resulted not significantly different. LDLT guarantees same long term results than DDLT if the selection criteria of candidates are analogues. Milan criteria remains a valid candidate selection tool to obtain optimal long term results in LDLT. An aggressive downstaging policy seems to improve the long-term results in LDLT, thus LRT may be considered useful to prevent tumor progression waiting for transplantation as well as a neoadjuvant therapy for HCC. A literature detailed meta-analysis could definitely clarify if LDLT is an independent risk factor for HCC recurrence.

1 January 2017 in Chirurgia
Verified
Journal Article
Closed access
SSStefano Di Sandro
Stefano Di Sandro
FFFabio Ferla
Fabio Ferla
Andrea LauterioAndrea Lauterio
Andrea Lauterio
IMIacopo Mangoni
Iacopo Mangoni
RCRiccardo De Carlis
Riccardo De Carlis
LCLuciano De Carlis
Luciano De Carlis
The main goal of allocation system is to guarantee an equal access to the limited resource of liver grafts for every class of patients on the waiting list, balancing between the ethical principles of equity, utility, benefit, need, and fairness. The aim of this review was to analyze liver allocation policies among these organizations, focusing on HCC. The European area considered for this analysis included 6 macro-areas or countries, which are congregated from the same policy of liver sharing and allocation. By this definition, the 6 areas identified are: Centro Nazionale Trapianti (CNT) in Italy; Eurotransplant (Germany, the Netherlands, Belgium, Luxembourg, Austria, Hungary, Slovenia, and Croatia); Organizacion Nacional de Transplantes (ONT) in Spain; Etablissement francais des Greffes (EfG) in France; NHS Blood Transplant (NHSBT) in the United Kingdom and Ireland; Scandiatransplant (Sweden, Norway, Finland, Denmark, and Iceland); Romanian National Policy. Each identified area, as network for organ sharing in Europe, adopts a basic allocation system that consider a policy center oriented or patient oriented. Priorization of patients affected by HCC in the waiting list for deceased donors liver transplant worldwide is dominated by 2 main principles: urgency and utility. The main message of this review is the absence of a common organs allocation policy over the Eurpean countries. Despite that, long-term survival of the community of patients listed for transplant due to HCC results, however, highly acceptable in Europe and comparable to the long-term survial reported in the UNOS register.

1 June 2014
Verified
Journal Article
Closed access
LCLuciano Gregorio De Carlis
Luciano Gregorio De Carlis
RSRaffaella Sguinzi
Raffaella Sguinzi
FFFabio Ferla
Fabio Ferla
SSStefano Di Sandro
Stefano Di Sandro
BDBogdan Dorobanţu
Bogdan Dorobanţu
CFCharles Ferrari
Charles Ferrari